Study on in Vivo Modulation of NK-kB signalling as the effector of anti-tumor effect of NSAID's

Project Details

StatusFinished
Effective start/end date1/11/0231/10/05

Funding

  • UK central government bodies/local authorities, health and hospital authorities: £148,984.00